Aspirine can prevent rectal cancer

According to a new study in British journal The Lancet , long-term intake of aspirine helps prevent colorectal cancer in people at high risk of inheriting the disease.

>>>Type 2 diabetes increases the risk of bowel cancer

The study was conducted with 861 people suffering from Lynch symptoms , a symptom that shows an increased risk of colorectal cancer as well as other types of cancer (ovaries, stomachs, etc.).

Half of them were given 600mg of aspirine daily for at least two years. The rest were given fake drugs.

The analysis of the first data in 2007 did not show the difference between the two groups, but in the past year there were 24 cases of colorectal cancer in those who took fake drugs compared to 19 cases in people using aspirine, a 44% reduction in risk of this disease.

Focusing on studying those who took aspirine for at least two years, the researchers found that the effect of the drug became more pronounced: The number of cases of rectal cancer has decreased by 63% with 23. The case of the disease in people taking counterfeit drugs compared to 10% in those who took aspirine.

Conducting additional studies for the study is necessary to determine the optimal dose of aspirine and the duration of treatment for colon cancer, according to Professor John Burnes of the University of Newcastle in England and colleagues. rectal with this medicine.